Population
Poliovirus type 1 (Mahoney) and rabbits inoculated with the hybrid virus
Design
Preclinical
Authors
Loading...
May guide multivalent poliovirus vaccine development; leaves open human safety and efficacy.
Manipulation of the N-AgII antigenic site is a viable method for producing hybrid polioviruses that induce neutralizing antibodies against multiple serotypes.
Murdin et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: